Animal Model For Drug Development

Abstract

The present invention relates to a non-human mammalian animal which has been modified to have in the blood, plasma and/or serum (a) an increased number of leukocytes and/or neutrophils, and (b) a reduced activity of the DNase 1 and/or DNase 1-like 3 enzymes. The non-human mammalian animal is particularly suitable for studying inflammation and/or a disease associated with inflammation. In a further aspect, the invention relates to the use of the non-human mammalian animal as a model for identifying therapeutic or diagnostic targets of inflammation and/or a disease associated with inflammation. In a still further aspect, the invention relates the use of the non-human mammalian animal as a model for drug candidate testing. In addition, a method for testing an anti-inflammatory drug candidate against extracellular DNA is provided. Finally, a method for testing an anti-inflammatory drug candidate for modifying the formation or degradation of neutrophil extracellular traps is provided. In still another aspect, the present invention relates to a non-human mammalian animal, which has been modified to have an increased number of neutrophils in blood.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 26, 2018
  • Application: Jan 22, 2018
    WO EP 2018051488 W
  • Priority: Oct 2, 2017
    EP EP 17194478 A
  • Priority: Jan 20, 2017
    EP EP 17152528 A

Download Citation


Sign in to the Lens

Feedback